- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 108.43M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $17.82M |
| Capex | Q1 2026 · Mar 31, 2025 | $5.36M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $120.11M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $29.46M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $244.62M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $230.17M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $505.44M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $392.2M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.13B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $708.16M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.53B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.89B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.47B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.11B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.48B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.68B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.13 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.24 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $116.1M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $69.46M |
| Net Income | Q1 2026 · Mar 31, 2026 | $16.09M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$21.21M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $22.37M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $16.55M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $186.15M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $111.7M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $851.74M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $394.25M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.04B |
| Revenue | Q1 2026 · Mar 31, 2025 | $505.95M |